vs
CARRIAGE SERVICES INC（CSV）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是CARRIAGE SERVICES INC的2.0倍（$207.3M vs $105.5M），CARRIAGE SERVICES INC净利率更高（11.6% vs -62.0%，领先73.7%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 8.0%），CARRIAGE SERVICES INC自由现金流更多（$6.2M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 1.0%）
怡和Cycle & Carriage有限公司是怡和集团在东南亚的投资控股公司，目前该集团持有其75%的股份，是怡和集团在东南亚区域开展资本布局与投资业务的核心平台。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
CSV vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $105.5M | $207.3M |
| 净利润 | $12.3M | $-128.6M |
| 毛利率 | 34.8% | — |
| 营业利润率 | 23.3% | -54.7% |
| 净利率 | 11.6% | -62.0% |
| 营收同比 | 8.0% | 25.9% |
| 净利润同比 | 24.5% | 3.5% |
| 每股收益（稀释后） | $0.76 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $105.5M | $207.3M | ||
| Q3 25 | $102.7M | $159.9M | ||
| Q2 25 | $102.1M | $166.5M | ||
| Q1 25 | $107.1M | $139.3M | ||
| Q4 24 | $97.7M | $164.6M | ||
| Q3 24 | $100.7M | $139.5M | ||
| Q2 24 | $102.3M | $147.0M | ||
| Q1 24 | $103.5M | $108.8M |
| Q4 25 | $12.3M | $-128.6M | ||
| Q3 25 | $6.6M | $-180.4M | ||
| Q2 25 | $11.7M | $-115.0M | ||
| Q1 25 | $20.9M | $-151.1M | ||
| Q4 24 | $9.9M | $-133.2M | ||
| Q3 24 | $9.9M | $-133.5M | ||
| Q2 24 | $6.3M | $-131.6M | ||
| Q1 24 | $7.0M | $-170.7M |
| Q4 25 | 34.8% | — | ||
| Q3 25 | 35.3% | — | ||
| Q2 25 | 35.2% | — | ||
| Q1 25 | 35.3% | — | ||
| Q4 24 | 34.4% | — | ||
| Q3 24 | 35.2% | — | ||
| Q2 24 | 36.2% | — | ||
| Q1 24 | 36.0% | — |
| Q4 25 | 23.3% | -54.7% | ||
| Q3 25 | 17.0% | -106.9% | ||
| Q2 25 | 23.5% | -64.8% | ||
| Q1 25 | 29.5% | -102.6% | ||
| Q4 24 | 21.6% | -74.3% | ||
| Q3 24 | 22.7% | -94.6% | ||
| Q2 24 | 18.0% | -79.1% | ||
| Q1 24 | 18.8% | -151.9% |
| Q4 25 | 11.6% | -62.0% | ||
| Q3 25 | 6.4% | -112.8% | ||
| Q2 25 | 11.5% | -69.0% | ||
| Q1 25 | 19.5% | -108.5% | ||
| Q4 24 | 10.1% | -80.9% | ||
| Q3 24 | 9.8% | -95.7% | ||
| Q2 24 | 6.1% | -89.5% | ||
| Q1 24 | 6.7% | -156.8% |
| Q4 25 | $0.76 | $-1.28 | ||
| Q3 25 | $0.41 | $-1.81 | ||
| Q2 25 | $0.74 | $-1.17 | ||
| Q1 25 | $1.34 | $-1.57 | ||
| Q4 24 | $0.62 | $-1.34 | ||
| Q3 24 | $0.63 | $-1.40 | ||
| Q2 24 | $0.40 | $-1.52 | ||
| Q1 24 | $0.45 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.7M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $254.8M | $-80.0M |
| 总资产 | $1.3B | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $1.7M | $421.0M | ||
| Q3 25 | $1.2M | $202.5M | ||
| Q2 25 | $1.4M | $176.3M | ||
| Q1 25 | $4.6M | $127.1M | ||
| Q4 24 | $1.2M | $174.0M | ||
| Q3 24 | $1.3M | $150.6M | ||
| Q2 24 | $1.5M | $480.7M | ||
| Q1 24 | $1.7M | $112.3M |
| Q4 25 | $254.8M | $-80.0M | ||
| Q3 25 | $242.1M | $9.2M | ||
| Q2 25 | $235.4M | $151.3M | ||
| Q1 25 | $223.1M | $144.2M | ||
| Q4 24 | $208.6M | $255.0M | ||
| Q3 24 | $198.1M | $346.8M | ||
| Q2 24 | $187.9M | $432.4M | ||
| Q1 24 | $179.6M | $140.3M |
| Q4 25 | $1.3B | $1.5B | ||
| Q3 25 | $1.3B | $1.2B | ||
| Q2 25 | $1.3B | $1.3B | ||
| Q1 25 | $1.3B | $1.3B | ||
| Q4 24 | $1.3B | $1.5B | ||
| Q3 24 | $1.3B | $1.5B | ||
| Q2 24 | $1.3B | $1.6B | ||
| Q1 24 | $1.3B | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.1M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $6.2M | $-100.8M |
| 自由现金流率自由现金流/营收 | 5.9% | -48.6% |
| 资本支出强度资本支出/营收 | 7.5% | 0.5% |
| 现金转化率经营现金流/净利润 | 1.15× | — |
| 过去12个月自由现金流最近4个季度 | $40.1M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $14.1M | $-99.8M | ||
| Q3 25 | $24.7M | $-91.4M | ||
| Q2 25 | $8.1M | $-108.3M | ||
| Q1 25 | $13.8M | $-166.5M | ||
| Q4 24 | $9.3M | $-79.3M | ||
| Q3 24 | $20.9M | $-67.0M | ||
| Q2 24 | $2.2M | $-77.0M | ||
| Q1 24 | $19.7M | $-190.7M |
| Q4 25 | $6.2M | $-100.8M | ||
| Q3 25 | $18.0M | $-92.7M | ||
| Q2 25 | $5.2M | $-110.7M | ||
| Q1 25 | $10.6M | $-167.8M | ||
| Q4 24 | $4.9M | $-79.5M | ||
| Q3 24 | $16.2M | $-68.6M | ||
| Q2 24 | $-1.4M | $-79.0M | ||
| Q1 24 | $16.2M | $-193.9M |
| Q4 25 | 5.9% | -48.6% | ||
| Q3 25 | 17.5% | -58.0% | ||
| Q2 25 | 5.1% | -66.5% | ||
| Q1 25 | 9.9% | -120.5% | ||
| Q4 24 | 5.0% | -48.3% | ||
| Q3 24 | 16.1% | -49.2% | ||
| Q2 24 | -1.4% | -53.7% | ||
| Q1 24 | 15.6% | -178.2% |
| Q4 25 | 7.5% | 0.5% | ||
| Q3 25 | 6.5% | 0.8% | ||
| Q2 25 | 2.8% | 1.5% | ||
| Q1 25 | 3.0% | 1.0% | ||
| Q4 24 | 4.5% | 0.1% | ||
| Q3 24 | 4.6% | 1.2% | ||
| Q2 24 | 3.5% | 1.4% | ||
| Q1 24 | 3.4% | 3.0% |
| Q4 25 | 1.15× | — | ||
| Q3 25 | 3.76× | — | ||
| Q2 25 | 0.69× | — | ||
| Q1 25 | 0.66× | — | ||
| Q4 24 | 0.94× | — | ||
| Q3 24 | 2.11× | — | ||
| Q2 24 | 0.34× | — | ||
| Q1 24 | 2.83× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CSV
| Propertyand Merchandise | $47.8M | 45% |
| Cemetery Interment Rights | $24.8M | 23% |
| Merchandise | $18.9M | 18% |
| Other Revenue | $10.2M | 10% |
| Other | $3.9M | 4% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
